Picture of Tianda Pharmaceuticals logo

455 Tianda Pharmaceuticals Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual cashflow statement for Tianda Pharmaceuticals, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line26.215.9-27.4-28
Depreciation
Amortisation
Non-Cash Items-4.93-5.38-3.96-11.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-18.2-50-26.88.91
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities19.2-19.9-37.6-8.23
Capital Expenditures-33.6-102-146-46.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-47.261.38.72133
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-80.9-41.1-13886.3
Financing Cash Flow Items0-14.5-6.94-0.887
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6.91-0.81290.8-1.29
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-100-81.2-63.785.8